Budesonide | Ambroxol + Budesonide B | Acetylcysteine + Budesonide | Statistical results | ||
---|---|---|---|---|---|
n = 24 | n = 28 | n = 30 | |||
Average age (years) | 5.70 ± 2.25 | 5.80 ± 2.58 | 5.18 ± 2.33 | F = 0.565 | P = 0.571 |
Gender(male/ female) | 13/11 | 14/14 | 16/14 | X2 = 0.105 | P = 0.949 |
hospital stay (days) | 13.33 ± 2.16 | 12.93 ± 2.18 | 12.65 ± 2.22 | F = 3.610 | P = 0.032 |
Pulmonary imaging | |||||
Unilateral lesion of a lobe or segment | 16 | 20 | 21 | X2 = 0.073 | P = 0.964 |
Bilateral lesions of a certain lobe or segment | 8 | 8 | 9 | ||
pleural effusion | 8 | 9 | 11 | X2 = 0.144 | P = 0.931 |
atelectasis | 9 | 10 | 12 | X2 = 0.114 | P = 0.944 |
pulmonary consolidation | 1 | 3 | 4 | X2 = 1.317 | P = 0.518 |
MP detection | |||||
MP-IgM Ab(+) | 12 | 13 | 13 | X2 = 0.238 | P = 0.888 |
MP-IgG Ab(≥ 1:160) | 17 | 21 | 23 | X2 = 0.246 | P = 0.884 |
MP-PCR DNA(+) | 19 | 22 | 24 | X2 = 0.018 | P = 0.991 |
Both two items were positive simultaneously | 21 | 25 | 27 | X2 = 0.088 | P = 0.957 |
Both three items were positive simultaneously | 3 | 3 | 3 | X2 = 0.088 | P = 0.957 |
Therapeutic drugs | |||||
Azithromycin + methylprednisolone | 12 | 13 | 13 | X2 = 2.705 | P = 0.951 |
Azithromycin + methylprednisolone + cefuroxime sodium injection | 6 | 6 | 5 | ||
Azithromycin + methylprednisolone + ceftriaxone sodium injection | 3 | 4 | 6 | ||
Azithromycin + methylprednisolone + piperacillin-tazobactam | 2 | 4 | 4 | ||
Azithromycin + methylprednisolone + cefoperazone sulbactam | 1 | 1 | 2 | ||
Number of BLA | |||||
One time | 18 | 22 | 27 | X2 = 2.870 | P = 0.058 |
Two times | 4 | 5 | 2 | ||
Three times | 2 | 1 | 1 | ||
Selection of bronchoscope diameter | |||||
diameter 4.0 mm | 23 | 26 | 29 | X2 = 0.490 | P = 0.783 |
diameter 2.8 mm | 1 | 2 | 1 |